Genetic and Nongenetic Risk Factors for Breast Cancer Risk Estimation
JAMA Network Open · 2025
DOI: 10.1001/jamanetworkopen.2025.5804 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA Network Open, 2025. Verfasst von Wenji Guo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois. Hauptthemen laut MEDLINE: Breast Neoplasms, Genetic Predisposition to Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIMHD NIH HHS, NIEHS NIH HHS.
Abstract (Originalsprache)
Importance Most breast cancers in Africa are diagnosed at advanced stages. Improved risk prediction tools to optimize screening and earlier diagnosis are urgently needed.
Objective
To build a comprehensive breast cancer risk estimation model by integrating a polygenic risk score (PRS), pathogenic variants (PVs) in high- or moderate-penetrance genes, and a questionnaire-based risk calculator. Design, Setting, and Participants This multicenter case-control study initially enrolled women in Nigeria in 1998 and expanded to Cameroon and Uganda in 2011; enrollment ended in 2018. Women with breast cancer (hereafter cases) were enrolled through hospital oncology units, whereas women without breast cancer (hereafter controls) were recruited from other outpatient clinics and the community. Participants whose genetic data were used in PRS development were excluded from the development of the comprehensive breast cancer risk estimation model. Analyses were performed from September 2023 to January 2025. Exposures Lifetime absolute risk estimation models that integrated a PRS only (previously developed using data from women of African ancestry and European ancestry), PRS plus PVs in high- or moderate-penetrance genes ( BRCA1 , BRCA2 , PALB2 , ATM , CHEK2 , TP53 , BARD1 , RAD51C , and RAD51D ), epidemiologic risk factors only (ascertained from NBCS questionnaires), and a combined model containing these 3 components. Main Outcomes and Measures Lifetime absolute risk of breast cancer was estimated, accounting for an association between family history and genetic factors. Participants’ lifetime estimated absolute risk was categorized by the following risk thresholds: lower than 3%, 3%, 5%, and 10% or higher.
Results
A total of 1686 women, of whom 996 were cases (mean [SD] age at enrollment, 49.5 [12.2] years) and 690 were controls (mean [SD] age at enrollment, 41.5 [13.8] years), were included in the main analyses. The age-adjusted area under the receiver operating characteristic curve (AUROC) was 0.579 (95% CI, 0.549-0.610) for the PRS only model and 0.609 (95% CI, 0.579-0.638) for the PRS plus PV model. In the combined model containing both genetic and nongenetic risk factors, age-adjusted AUROC increased to 0.723 (95% CI, 0.698-0.748). Using a threshold of 10% or higher lifetime absolute risk, the combined model classified 12.0% of cases (120) as high risk compared with 3.7% of cases (37) using the epidemiologic factors only model and 5.0% of cases (50) using the PRS plus PV model. Conclusions and Relevance In this case-control study, a breast cancer risk estimation model was developed that combines genetic and nongenetic factors and refines a previous model that includes epidemiologic risk factors. Further development and validation of this model are necessary to advance breast cancer risk assessment in sub-Saharan Africa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
- Department of Public Health Sciences, The University of Chicago, Chicago, Illinois.
- Department of Radiation Oncology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
- Center for Population and Reproductive Health, College of Medicine, University of Ibadan, Ibadan, Nigeria.
- Department of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria.
- Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Förderung
- NCI NIH HHS
- NIMHD NIH HHS
- NIEHS NIH HHS
- NHGRI NIH HHS
Zitieren
APA
Guo, W., Li, J. L., McClellan, J., Ntekim, A., Ojengbede, O., Ogundiran, T., Odetunde, A., Obafunwa, J., Popoola, A., Ndom, P., Gakwaya, A., Chatterjee, N., Sveen, E., Yoshimatsu, T. F., Zheng, Y., Olopade, O. I., & Huo, D. (2025). Genetic and Nongenetic Risk Factors for Breast Cancer Risk Estimation. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.5804
Vancouver
Guo W, Li JL, McClellan J, Ntekim A, Ojengbede O, Ogundiran T, et al. Genetic and Nongenetic Risk Factors for Breast Cancer Risk Estimation. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.5804
BibTeX
@article{Guo2025,
author = {Guo, Wenji and Li, James L and McClellan, Julian and Ntekim, Atara and Ojengbede, Oladosu and Ogundiran, Temidayo and Odetunde, Abayomi and Obafunwa, John and Popoola, Abiodun and Ndom, Paul and Gakwaya, Antony and Chatterjee, Nilanjan and Sveen, Elisabeth and Yoshimatsu, Toshio F and Zheng, Yonglan and Olopade, Olufunmilayo I and Huo, Dezheng},
title = {Genetic and Nongenetic Risk Factors for Breast Cancer Risk Estimation},
journal = {JAMA Network Open},
year = {2025},
doi = {10.1001/jamanetworkopen.2025.5804}
}
EUVIMED